Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(1)
•••
Post by sunny3999on Sep 26, 2018 12:09am
248 Views
Post# 28690195

To be considered!

To be considered! I find the consolidation at Aphria on the level very positive because both Aurora and Canopy have gap-ups that will eventually be closed and that you should always remember.

The healthy gradual increase takes out the volatility at Aphria and still has a very good potential up compared to the others - especially since Aphria is the undervalued stock of all three.

If something happens at Aphria, there should be a nice development because of the Mkap comparison
  • Canopy = 15.84 billion Mkap
  • Aurora = 12.23 billion Mkap 
  • Aphria = 4.6 billion Mkap

Everyone can imagine for themselves, which of the three has the most potential, when rubber hits the road with the US listing and partner news.

Personally I bet on Aphria - That's why I have the lion's share here!

Just my 2 Cents
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities